Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Lifestyle Modification in Hypothyroidism with Insulin Resistance
NCT06096454Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Nov 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of metformin in insulin resistance (IR) (2 arms), sponsored by Assiut University. Primary endpoints: change of waist circumference at 6 months, Dose of levothyroxine at 6 months and 1 more. Status: unknown.
02
Drugs
metformin
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT06096454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06096454.